Jun 30, 2021 Lock in Big Gains in BEAM Hi Savio, Two days ago, we locked in 300%+ profits in Intellia Therapeutics (NTLA) as good news caused it and most gene therapy stocks to surge. Today, we’re taking advantage and locking in even bigger profits in Beam Therapeutics (BEAM). Beam is up more than 330% for us in just a little over eight months, which is huge. The stock is up nearly 20% again today and over 40% just this week on the back of the groundbreaking news from Intellia. Beam is in the same gene therapy trend, but it does take a different approach than Intellia. More importantly, it is still years away from any potential treatment. That means now is a great time to take our juicy profits. Let me be clear that I am not saying Beam does not have a bright future. It does, and it could again be a great investment at the right price. For now, we are sitting on big profits, and we know that there will be a lot of volatility in the years ahead for gene therapy stocks and especially Beam due to its early stage development of a treatment. Sell BEAM and enjoy the gains. It’s been a great week for us! Sincerely, Matt McCall Editor, Early Stage Investor |
Comments
Post a Comment